PMID: 15220671Jun 29, 2004Paper

Probiotics in the treatment of irritable bowel syndrome

Journal of Clinical Gastroenterology
Alfredo Saggioro

Abstract

Irritable Bowel Syndrome (IBS) may be diagnosed on the presence of symptoms, according to Rome II criteria, [corrected] and some studies have shown that abnormal colonic fermentation may be an important factor in the development of symptoms in some patients with IBS. Since the fermentation [corrected] of substrates by the intestinal flora may play a key role in the use of probiotics in the treatment of IBS, seventy [corrected] patients (31 [corrected] males, 39 [corrected] females), mean age 40 years (range = 26-64 years) with IBS, according to Rome II criteria, were enrolled into the study after informed consensus. Patients were randomly assigned to receive for 4 weeks [corrected] either the active preparation containing Lactobacillus plantarum LP 01 [corrected] and Bifidobacterium breve BR 03 [corrected] or Lactobacillus plantarum LP 01 and Lactobacillus acidophilus LA 02, all strains at concentrations of 5 x 10(9) CFU/g) [corrected] or placebo powder containing starch identical to the study product [corrected] To evaluate treatment efficacy two different scores were considered [corrected] Pain score in different abdominal locations after treatment decreased in probiotics groups A and B 42% and 49% versus 25% [corrected] (P <...Continue Reading

References

Jun 1, 1991·The Journal of Applied Bacteriology·J H Cummings, G T Macfarlane
May 1, 1987·The American Journal of Clinical Nutrition·J H Cummings, H N Englyst
Oct 20, 1998·Lancet·T S KingJ O Hunter
Nov 17, 2001·European Journal of Gastroenterology & Hepatology·W G Thompson
Nov 1, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·G BazzocchiM Campieri

❮ Previous
Next ❯

Citations

May 10, 2008·Diseases of the Colon and Rectum·Shekoufeh NikfarMohammad Abdollahi
Nov 2, 2006·Digestive Diseases and Sciences·Linda S KimRobert F Waters
Sep 1, 2007·Current Treatment Options in Gastroenterology·Robin C Spiller
Nov 6, 2007·The British Journal of Nutrition·Xenofon TzounisJeremy P E Spencer
Nov 3, 2005·Nature Clinical Practice. Gastroenterology & Hepatology·Elizabeth Furrie
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen Tamayo
Oct 10, 2006·Applied and Environmental Microbiology·Yong Jun GohRobert W Hutkins
Sep 28, 2007·Canadian Journal of Microbiology·Christian BleauLucie Lamontagne
Feb 18, 2009·BMC Gastroenterology·Nourieh HoveydaPaul Glasziou
Jan 1, 2012·Microbial Ecology in Health and Disease·Riitta Korpela, Leena Niittynen
May 8, 2008·World Journal of Gastroenterology : WJG·Lynne V McFarland, Sascha Dublin
Jun 18, 2009·World Journal of Gastroenterology : WJG·Angèle P M KerckhoffsLouis M A Akkermans
Apr 17, 2010·World Journal of Gastroenterology : WJG·Li-Xuan SangMin Jiang
Jan 4, 2013·Nutrition Reviews·Manoj KumarBirbal Singh
Jul 27, 2005·Current Gastroenterology Reports·Michael D CrowellLin Chang
Aug 24, 2013·Scandinavian Journal of Gastroenterology·Leonilde BonfratePiero Portincasa
Aug 18, 2012·Expert Opinion on Biological Therapy·Asieh HosseiniMohammad Abdollahi
Nov 28, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Borja SánchezAbelardo Margolles
Mar 18, 2011·International Journal of Food Microbiology·Sawaminee Nualkaekul, Dimitris Charalampopoulos
May 3, 2007·Gastroenterology Clinics of North America·Jacqueline Park, Martin H Floch
Jan 30, 2007·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Michael Camilleri
Sep 28, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·H J KimA R Zinsmeister
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·T LiebregtsG Holtmann
Jan 19, 2007·Alimentary Pharmacology & Therapeutics·A GawrońskaH Szajewska
Apr 14, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·W FeleszkoE Hamelmann
Jan 8, 2008·Alimentary Pharmacology & Therapeutics·D Jonkers, R Stockbrügger
Jan 10, 2012·Alimentary Pharmacology & Therapeutics·G ClarkeE M Quigley
Aug 21, 2015·Alimentary Pharmacology & Therapeutics·Z MujagicA A M Masclee
Sep 10, 2015·Journal of Neurogastroenterology and Motility·Nazar MazurakPaul Enck
Jan 18, 2006·Nutrition·Edoardo G GianniniVincenzo Savarino
Dec 3, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Jee-Yon LeeNam-Kyu Kim
Feb 19, 2011·Journal of Medical Microbiology·Kannan PonnusamyChoong Hwan Lee
Mar 4, 2008·Journal of the American Dietetic Association·Linda C Douglas, Mary E Sanders
Apr 7, 2015·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Luigi RussoRosario Cuomo
May 15, 2012·Biochemical and Biophysical Research Communications·Akiko YasudaHirohisa Takano
Oct 16, 2016·Journal of Clinical Gastroenterology·Mario Del PianoLuca Mogna
Jul 30, 2005·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Eva NivNachum Vaisman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.